Monday, June 22, 2020 4:47:52 PM
If TLD does not happen in July, it will most likely happen in August. I don't believe that NWBO can or will blame the CRO when everyone knows that COVID-19 is mostly at fault.
Having said that, I do believe that NWBO took a risk when they added the IDH mutation work to the trial. Maybe they greatly underestimated the time that it would take to complete this work during a COVID-19 pandemic. I am guessing that absent the IDH mutation work, TLD would have been revealed weeks ago.
If anyone feels that the results will not be good, he or she should cash out. However, any further delay will not affect good or bad results which by now are set in stone.
Since I believe the results to be excellent, I will not sell my shares despite the fact that TDL may be delayed for a few more weeks or months. I have waited too long for this to end and I will stick it out even if TLD is postponed for a few more months.
Having said that, I do believe that NWBO took a risk when they added the IDH mutation work to the trial. Maybe they greatly underestimated the time that it would take to complete this work during a COVID-19 pandemic. I am guessing that absent the IDH mutation work, TLD would have been revealed weeks ago.
If anyone feels that the results will not be good, he or she should cash out. However, any further delay will not affect good or bad results which by now are set in stone.
Since I believe the results to be excellent, I will not sell my shares despite the fact that TDL may be delayed for a few more weeks or months. I have waited too long for this to end and I will stick it out even if TLD is postponed for a few more months.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
